# DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)

> **NCT00664066** · — · TERMINATED · sponsor: **Shire** · enrollment: 3 (actual)

## Conditions studied

- Anemia
- Kidney Diseases
- Renal Failure, Chronic
- Kidney Failure, Chronic

## Interventions

- **DRUG:** DYNEPO (epoetin delta)

## Key facts

- **NCT ID:** NCT00664066
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2008-04-25
- **Primary completion:** 2008-07-30
- **Final completion:** 2008-07-30
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** The termination of the study is not linked to a product recall or result of any safety signal. Rather it was sponsor's commercial decision to withdraw the MA
- **Last updated:** 2021-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00664066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00664066, "DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00664066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*